A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission
Katerina Chatzidionysiou, Carl Turesson, Annika Teleman, Ann Knight, Elisabet Lindqvist, Per Larsson, Lars Cöster, Kristina Forslind, Ronald van Vollenhoven, Mikael Heimbürger
RMD Open Jan 2016, 2 (1) e000133; DOI: 10.1136/rmdopen-2015-000133